Apple

Joe Kiani, Masimo's CEO, discusses the company's patent infringement lawsuit against Apple, alleging Apple recruited Masimo employees and used its IP. Kiani also talks about Masimo's innovations in medical devices, the impact of AI on healthcare, and the challenges of leading amidst legal battles and shareholder disputes.

The FDA approved Apple's new Atrial Fibrillation History Feature, enabling heart rhythm analysis on Apple Watch. It monitors Afib between 50-150 or 50-120 BPM, depending on the region. Its debut, whether in watchOS 9 or a new model, remains unclear.

Google's Fitbit received FDA approval for a new algorithm enabling continuous heart rhythm monitoring, similar to Apple Watch's AFib detection. The PPG algorithm, validated by the Fitbit Heart Study, identifies AFib with 98% accuracy. This feature will soon be available on U.S. Fitbit devices, as Apple enhances its Watch's health features.

Silicon Valley leaders, including Google and Kleiner Perkins, formed Calico to combat aging. Art Levinson, Apple chairman and Calico CEO, met with Google's Larry Page to discuss this ambitious project, driven by the intriguing potential to halt aging, following initial skepticism.

Google's Calico, launched in 2013, aims to combat aging and associated diseases through advanced technologies and drug development, partnering with AbbVie. With a focus on extending human life, Calico's research includes mouse models and yeast cells to understand aging. Despite secrecy, the project reflects Google's interest in radical life extension and technological singularity.

AliveCor's KardiaK software platform received FDA breakthrough device designation for non-invasive hyperkalemia screening using ECG data. It aims to help users with kidney disease monitor their condition at home, potentially saving lives and healthcare costs. The platform utilizes AI to analyze ECG data from devices like KardiaMobile and KardiaBand.